Standard BioTools regains Nasdaq minimum bid price compliance

STANDARD BIOTOOLS INC.

Received Nasdaq letter on June 5, 2026 confirming compliance with Bid Price Requirement.
Previously notified of deficiency on April 20, 2026 due to bid price below $1.00 for 30 consecutive days.
Matter is now closed; no further action required.

item 8.01

STANDARD BIOTOOLS INC. filing history →

Source: SEC EDGAR

accession 0001193125-26-259877

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.